Diphtheria primarily affects the respiratory tract and can lead to severe complications if left untreated. Here is an overview of the epidemiology of Corynebacterium diphtheriae:
The bacterium is usually transmitted through respiratory droplets from an infected person. Additionally, it can be spread by touching skin lesions or touching contaminated objects.
Diphtheria is found worldwide, but it is more common in developing countries with inadequate immunization programs and limited access to healthcare. Diphtheria was a significant cause of illness and death in the past, but widespread vaccination efforts have significantly reduced its incidence.
Immunization has been essential in preventing diphtheria. The diphtheria toxoid vaccine, often given as part of the combined diphtheria-tetanus-pertussis (DTP) vaccine, is highly effective in preventing the disease. Routine childhood immunization programs have successfully reduced the global burden of diphtheria.
Some individuals, known as carriers, can harbor and spread the bacterium without showing disease symptoms. These carriers can serve as a reservoir for transmission. The bacterium can also colonize the skin or mucous membranes without causing disease.
Factors that increase the risk of diphtheria include:
Only complete or adequate immunization.
Crowded living conditions.
Poor hygiene.
Limited access to healthcare.
Unvaccinated or under-vaccinated individuals, including infants and older adults, are more susceptible to the disease.
Although diphtheria is well-controlled in many parts of the world, outbreaks can occur, particularly in areas with low vaccination coverage. These outbreaks may increase morbidity and mortality, especially among unvaccinated individuals.
Corynebacterium diphtheriae is a gram-positive bacterium responsible for causing the infectious disease known as diphtheria. It is classified as follows:
Domain: Bacteria
Phylum: Actinobacteria
Class: Actinobacteria
Order: Mycobacteriales
Family: Corynebacteriaceae
Genus: Corynebacterium
Species: C. diphtheria
It has a complex cellular structure with the following main components:
Cell Envelope: The cell envelope of C. diphtheria consists of three layers: a. Plasma Membrane: A phospholipid bilayer that separates the cytoplasm from the external environment and regulates the passage of substances.
Peptidoglycan Layer: A rigid mesh-like structure composed of peptidoglycan molecules, which provide structural integrity to the cell wall. c. Outer Membrane (in some strains): Present only in certain strains of C. diphtheria, this layer contains lipopolysaccharides (LPS) and other surface proteins.
Capsule: Some strains of C. diphtheria produce a capsule, a thick layer of polysaccharides surrounding the bacterial cell. The capsule helps protect the bacterium from the host immune system and enhances its ability to cause disease.
Pili and Fimbriae: C. diphtheria may possess pili and fimbriae, thin, filamentous appendages extending from the cell surface. These structures play a role in adherence to host cells and the formation of biofilms.
Flagella: C. diphtheria is generally non-motile and lacks flagella, which are whip-like structures involved in bacterial locomotion.
Toxin Production: One of the defining characteristics of C. diphtheria is its ability to produce a potent toxin called diphtheria toxin. The toxin is encoded by a bacteriophage (the virus that infects bacteria) and released into the surrounding environment, leading to the characteristic symptoms of diphtheria.
There are several different antigenic kinds of C. diphtheria, and recognizing these antigenic types is crucial for understanding the occurrence and prevention of diphtheria.
Recent clinical isolates of C. diphtheria from various nations and regions were found to contain multiple tox and dix alleles that encode identical DT proteins as well as multiple dtxR alleles that encode five different variants of the global regulatory protein DtxR, which represses the production of DT.
Recent clinical isolates of C. diphtheria generate a single antigenic type of diphtheria toxin (DT), which is the predominant virulence component of the bacterium, according to research by Murphy et al. A vaccine called diphtheria toxoid, a modified version of DT, is used to create immunity against diphtheria.
In locations where diphtheria is prevalent, asymptomatic nasopharyngeal carriage is very common. By increasing & releasing the toxin from diphtheria in the nasopharyngeal or as cutaneous lesions, toxic strains infect susceptible individuals.
The diphtheritic lesion is typically covered by a fibrin, bacterial, and inflammatory cell pseudomembrane. By means of proteolytic cleavage, diphtheria toxin’s N-terminal segments A (the catalytic domain) and B (the transmembrane & receptor binding domains) can be divided.
Fragment An ADP-ribosylates elongation factor 2 in an NAD+-dependent manner, preventing eukaryotic cells from synthesizing proteins. Fragment B facilitates the access of fragment A to the cytoplasm by binding to the cell membrane receptor.
Antitoxin antibodies stop DT from attaching to host cell membrane receptors and moving into the cytoplasm.
A diphtheria toxoid vaccine, a modified version of DT, creates immunity against diphtheria.
Activating the NFk transduction pathway in eukaryotic cells, which releases pro-inflammatory cytokines and chemokines that attract immune cells to the infection location, is one of C. diphtheria’s host defense mechanisms. Additionally, C. diphtheria can cause nitrosative and oxidative stress in the host cells, harming the bacterium’s DNA, proteins, and membranes.
C. diphtheria has certain defenses in place, including OxyR, a transcriptional regulator that regulates the production of antioxidant enzymes.
The main clinical sign is the development of a thick, grayish-white membrane in the nose or throat that can restrict the airway and make breathing difficult.
Other common clinical manifestations include:
A severe sore throat usually affects patients and may worsen with time.
Temperature: A high temperature, often exceeding 38°C (100.4°F), is frequently present.
Swollen lymph nodes: The cervical lymph nodes in the neck may expand and become painful.
Weakness and malaise: Patients may experience fatigue, malaise, and weakness.
Hoarseness and speech difficulties: The infection may damage the vocal cords, causing hoarseness and speaking difficulties.
In severe cases or when the bacteria release toxins into the bloodstream, diphtheria can cause systemic complications, such as:
Myocarditis: The heart muscle can become inflamed, which can cause cardiac problems and even heart failure.
Neurological issues: Diphtheria toxin effects on the nervous system can cause paralysis and other neurological problems.
When diagnosing Corynebacterium diphtheriae in a lab, the organism must first be isolated, and its toxin production must then be shown.
Sample: Swabs (ideally two), one for direct inspection and the other for culture, or a piece of the pseudomembrane, from the lesion of the throat, larynx, or nasal cavity.
simple investigation: Gramme, methylene blue, or Albert stains should be applied to the throat swab smears. The presence of many pleomorphic (usually organized in Chinese letter or cuneiform) gram-positive rods that are tapering, unevenly pigmented, and numerous implies Corynebacterium diphtheria. Typical metachromatic granules can be detected in methylene blue or Albert stain. In Albert stain, C. diphtheria is represented as green bacilli with bluish-black metachromatic granules.
Culture: Fastidious Corynebacterium diphtheria does not flourish on typical media. The sample should be cultivated on a selective and differential medium, such as cystine-tellurite blood agar and modified Tinsdale’s medium, to prevent the growth of commensals and to distinguish between diverse biotypes.
Corynebacterium diphtheria may be controlled by doing things like:
Isolating the sick individual until a culture is negative.
Treating the sick individual with antibiotics and antitoxin
Testing and treating the infected person’s close contact with antibiotics and advising them to get the necessary vaccinations.
Keeping up with proper hygiene and steering clear of contaminated things or skin blemishes
Diphtheria primarily affects the respiratory tract and can lead to severe complications if left untreated. Here is an overview of the epidemiology of Corynebacterium diphtheriae:
The bacterium is usually transmitted through respiratory droplets from an infected person. Additionally, it can be spread by touching skin lesions or touching contaminated objects.
Diphtheria is found worldwide, but it is more common in developing countries with inadequate immunization programs and limited access to healthcare. Diphtheria was a significant cause of illness and death in the past, but widespread vaccination efforts have significantly reduced its incidence.
Immunization has been essential in preventing diphtheria. The diphtheria toxoid vaccine, often given as part of the combined diphtheria-tetanus-pertussis (DTP) vaccine, is highly effective in preventing the disease. Routine childhood immunization programs have successfully reduced the global burden of diphtheria.
Some individuals, known as carriers, can harbor and spread the bacterium without showing disease symptoms. These carriers can serve as a reservoir for transmission. The bacterium can also colonize the skin or mucous membranes without causing disease.
Factors that increase the risk of diphtheria include:
Only complete or adequate immunization.
Crowded living conditions.
Poor hygiene.
Limited access to healthcare.
Unvaccinated or under-vaccinated individuals, including infants and older adults, are more susceptible to the disease.
Although diphtheria is well-controlled in many parts of the world, outbreaks can occur, particularly in areas with low vaccination coverage. These outbreaks may increase morbidity and mortality, especially among unvaccinated individuals.
Corynebacterium diphtheriae is a gram-positive bacterium responsible for causing the infectious disease known as diphtheria. It is classified as follows:
Domain: Bacteria
Phylum: Actinobacteria
Class: Actinobacteria
Order: Mycobacteriales
Family: Corynebacteriaceae
Genus: Corynebacterium
Species: C. diphtheria
It has a complex cellular structure with the following main components:
Cell Envelope: The cell envelope of C. diphtheria consists of three layers: a. Plasma Membrane: A phospholipid bilayer that separates the cytoplasm from the external environment and regulates the passage of substances.
Peptidoglycan Layer: A rigid mesh-like structure composed of peptidoglycan molecules, which provide structural integrity to the cell wall. c. Outer Membrane (in some strains): Present only in certain strains of C. diphtheria, this layer contains lipopolysaccharides (LPS) and other surface proteins.
Capsule: Some strains of C. diphtheria produce a capsule, a thick layer of polysaccharides surrounding the bacterial cell. The capsule helps protect the bacterium from the host immune system and enhances its ability to cause disease.
Pili and Fimbriae: C. diphtheria may possess pili and fimbriae, thin, filamentous appendages extending from the cell surface. These structures play a role in adherence to host cells and the formation of biofilms.
Flagella: C. diphtheria is generally non-motile and lacks flagella, which are whip-like structures involved in bacterial locomotion.
Toxin Production: One of the defining characteristics of C. diphtheria is its ability to produce a potent toxin called diphtheria toxin. The toxin is encoded by a bacteriophage (the virus that infects bacteria) and released into the surrounding environment, leading to the characteristic symptoms of diphtheria.
There are several different antigenic kinds of C. diphtheria, and recognizing these antigenic types is crucial for understanding the occurrence and prevention of diphtheria.
Recent clinical isolates of C. diphtheria from various nations and regions were found to contain multiple tox and dix alleles that encode identical DT proteins as well as multiple dtxR alleles that encode five different variants of the global regulatory protein DtxR, which represses the production of DT.
Recent clinical isolates of C. diphtheria generate a single antigenic type of diphtheria toxin (DT), which is the predominant virulence component of the bacterium, according to research by Murphy et al. A vaccine called diphtheria toxoid, a modified version of DT, is used to create immunity against diphtheria.
In locations where diphtheria is prevalent, asymptomatic nasopharyngeal carriage is very common. By increasing & releasing the toxin from diphtheria in the nasopharyngeal or as cutaneous lesions, toxic strains infect susceptible individuals.
The diphtheritic lesion is typically covered by a fibrin, bacterial, and inflammatory cell pseudomembrane. By means of proteolytic cleavage, diphtheria toxin’s N-terminal segments A (the catalytic domain) and B (the transmembrane & receptor binding domains) can be divided.
Fragment An ADP-ribosylates elongation factor 2 in an NAD+-dependent manner, preventing eukaryotic cells from synthesizing proteins. Fragment B facilitates the access of fragment A to the cytoplasm by binding to the cell membrane receptor.
Antitoxin antibodies stop DT from attaching to host cell membrane receptors and moving into the cytoplasm.
A diphtheria toxoid vaccine, a modified version of DT, creates immunity against diphtheria.
Activating the NFk transduction pathway in eukaryotic cells, which releases pro-inflammatory cytokines and chemokines that attract immune cells to the infection location, is one of C. diphtheria’s host defense mechanisms. Additionally, C. diphtheria can cause nitrosative and oxidative stress in the host cells, harming the bacterium’s DNA, proteins, and membranes.
C. diphtheria has certain defenses in place, including OxyR, a transcriptional regulator that regulates the production of antioxidant enzymes.
The main clinical sign is the development of a thick, grayish-white membrane in the nose or throat that can restrict the airway and make breathing difficult.
Other common clinical manifestations include:
A severe sore throat usually affects patients and may worsen with time.
Temperature: A high temperature, often exceeding 38°C (100.4°F), is frequently present.
Swollen lymph nodes: The cervical lymph nodes in the neck may expand and become painful.
Weakness and malaise: Patients may experience fatigue, malaise, and weakness.
Hoarseness and speech difficulties: The infection may damage the vocal cords, causing hoarseness and speaking difficulties.
In severe cases or when the bacteria release toxins into the bloodstream, diphtheria can cause systemic complications, such as:
Myocarditis: The heart muscle can become inflamed, which can cause cardiac problems and even heart failure.
Neurological issues: Diphtheria toxin effects on the nervous system can cause paralysis and other neurological problems.
When diagnosing Corynebacterium diphtheriae in a lab, the organism must first be isolated, and its toxin production must then be shown.
Sample: Swabs (ideally two), one for direct inspection and the other for culture, or a piece of the pseudomembrane, from the lesion of the throat, larynx, or nasal cavity.
simple investigation: Gramme, methylene blue, or Albert stains should be applied to the throat swab smears. The presence of many pleomorphic (usually organized in Chinese letter or cuneiform) gram-positive rods that are tapering, unevenly pigmented, and numerous implies Corynebacterium diphtheria. Typical metachromatic granules can be detected in methylene blue or Albert stain. In Albert stain, C. diphtheria is represented as green bacilli with bluish-black metachromatic granules.
Culture: Fastidious Corynebacterium diphtheria does not flourish on typical media. The sample should be cultivated on a selective and differential medium, such as cystine-tellurite blood agar and modified Tinsdale’s medium, to prevent the growth of commensals and to distinguish between diverse biotypes.
Corynebacterium diphtheria may be controlled by doing things like:
Isolating the sick individual until a culture is negative.
Treating the sick individual with antibiotics and antitoxin
Testing and treating the infected person’s close contact with antibiotics and advising them to get the necessary vaccinations.
Keeping up with proper hygiene and steering clear of contaminated things or skin blemishes
Diphtheria primarily affects the respiratory tract and can lead to severe complications if left untreated. Here is an overview of the epidemiology of Corynebacterium diphtheriae:
The bacterium is usually transmitted through respiratory droplets from an infected person. Additionally, it can be spread by touching skin lesions or touching contaminated objects.
Diphtheria is found worldwide, but it is more common in developing countries with inadequate immunization programs and limited access to healthcare. Diphtheria was a significant cause of illness and death in the past, but widespread vaccination efforts have significantly reduced its incidence.
Immunization has been essential in preventing diphtheria. The diphtheria toxoid vaccine, often given as part of the combined diphtheria-tetanus-pertussis (DTP) vaccine, is highly effective in preventing the disease. Routine childhood immunization programs have successfully reduced the global burden of diphtheria.
Some individuals, known as carriers, can harbor and spread the bacterium without showing disease symptoms. These carriers can serve as a reservoir for transmission. The bacterium can also colonize the skin or mucous membranes without causing disease.
Factors that increase the risk of diphtheria include:
Only complete or adequate immunization.
Crowded living conditions.
Poor hygiene.
Limited access to healthcare.
Unvaccinated or under-vaccinated individuals, including infants and older adults, are more susceptible to the disease.
Although diphtheria is well-controlled in many parts of the world, outbreaks can occur, particularly in areas with low vaccination coverage. These outbreaks may increase morbidity and mortality, especially among unvaccinated individuals.
Corynebacterium diphtheriae is a gram-positive bacterium responsible for causing the infectious disease known as diphtheria. It is classified as follows:
Domain: Bacteria
Phylum: Actinobacteria
Class: Actinobacteria
Order: Mycobacteriales
Family: Corynebacteriaceae
Genus: Corynebacterium
Species: C. diphtheria
It has a complex cellular structure with the following main components:
Cell Envelope: The cell envelope of C. diphtheria consists of three layers: a. Plasma Membrane: A phospholipid bilayer that separates the cytoplasm from the external environment and regulates the passage of substances.
Peptidoglycan Layer: A rigid mesh-like structure composed of peptidoglycan molecules, which provide structural integrity to the cell wall. c. Outer Membrane (in some strains): Present only in certain strains of C. diphtheria, this layer contains lipopolysaccharides (LPS) and other surface proteins.
Capsule: Some strains of C. diphtheria produce a capsule, a thick layer of polysaccharides surrounding the bacterial cell. The capsule helps protect the bacterium from the host immune system and enhances its ability to cause disease.
Pili and Fimbriae: C. diphtheria may possess pili and fimbriae, thin, filamentous appendages extending from the cell surface. These structures play a role in adherence to host cells and the formation of biofilms.
Flagella: C. diphtheria is generally non-motile and lacks flagella, which are whip-like structures involved in bacterial locomotion.
Toxin Production: One of the defining characteristics of C. diphtheria is its ability to produce a potent toxin called diphtheria toxin. The toxin is encoded by a bacteriophage (the virus that infects bacteria) and released into the surrounding environment, leading to the characteristic symptoms of diphtheria.
There are several different antigenic kinds of C. diphtheria, and recognizing these antigenic types is crucial for understanding the occurrence and prevention of diphtheria.
Recent clinical isolates of C. diphtheria from various nations and regions were found to contain multiple tox and dix alleles that encode identical DT proteins as well as multiple dtxR alleles that encode five different variants of the global regulatory protein DtxR, which represses the production of DT.
Recent clinical isolates of C. diphtheria generate a single antigenic type of diphtheria toxin (DT), which is the predominant virulence component of the bacterium, according to research by Murphy et al. A vaccine called diphtheria toxoid, a modified version of DT, is used to create immunity against diphtheria.
In locations where diphtheria is prevalent, asymptomatic nasopharyngeal carriage is very common. By increasing & releasing the toxin from diphtheria in the nasopharyngeal or as cutaneous lesions, toxic strains infect susceptible individuals.
The diphtheritic lesion is typically covered by a fibrin, bacterial, and inflammatory cell pseudomembrane. By means of proteolytic cleavage, diphtheria toxin’s N-terminal segments A (the catalytic domain) and B (the transmembrane & receptor binding domains) can be divided.
Fragment An ADP-ribosylates elongation factor 2 in an NAD+-dependent manner, preventing eukaryotic cells from synthesizing proteins. Fragment B facilitates the access of fragment A to the cytoplasm by binding to the cell membrane receptor.
Antitoxin antibodies stop DT from attaching to host cell membrane receptors and moving into the cytoplasm.
A diphtheria toxoid vaccine, a modified version of DT, creates immunity against diphtheria.
Activating the NFk transduction pathway in eukaryotic cells, which releases pro-inflammatory cytokines and chemokines that attract immune cells to the infection location, is one of C. diphtheria’s host defense mechanisms. Additionally, C. diphtheria can cause nitrosative and oxidative stress in the host cells, harming the bacterium’s DNA, proteins, and membranes.
C. diphtheria has certain defenses in place, including OxyR, a transcriptional regulator that regulates the production of antioxidant enzymes.
The main clinical sign is the development of a thick, grayish-white membrane in the nose or throat that can restrict the airway and make breathing difficult.
Other common clinical manifestations include:
A severe sore throat usually affects patients and may worsen with time.
Temperature: A high temperature, often exceeding 38°C (100.4°F), is frequently present.
Swollen lymph nodes: The cervical lymph nodes in the neck may expand and become painful.
Weakness and malaise: Patients may experience fatigue, malaise, and weakness.
Hoarseness and speech difficulties: The infection may damage the vocal cords, causing hoarseness and speaking difficulties.
In severe cases or when the bacteria release toxins into the bloodstream, diphtheria can cause systemic complications, such as:
Myocarditis: The heart muscle can become inflamed, which can cause cardiac problems and even heart failure.
Neurological issues: Diphtheria toxin effects on the nervous system can cause paralysis and other neurological problems.
When diagnosing Corynebacterium diphtheriae in a lab, the organism must first be isolated, and its toxin production must then be shown.
Sample: Swabs (ideally two), one for direct inspection and the other for culture, or a piece of the pseudomembrane, from the lesion of the throat, larynx, or nasal cavity.
simple investigation: Gramme, methylene blue, or Albert stains should be applied to the throat swab smears. The presence of many pleomorphic (usually organized in Chinese letter or cuneiform) gram-positive rods that are tapering, unevenly pigmented, and numerous implies Corynebacterium diphtheria. Typical metachromatic granules can be detected in methylene blue or Albert stain. In Albert stain, C. diphtheria is represented as green bacilli with bluish-black metachromatic granules.
Culture: Fastidious Corynebacterium diphtheria does not flourish on typical media. The sample should be cultivated on a selective and differential medium, such as cystine-tellurite blood agar and modified Tinsdale’s medium, to prevent the growth of commensals and to distinguish between diverse biotypes.
Corynebacterium diphtheria may be controlled by doing things like:
Isolating the sick individual until a culture is negative.
Treating the sick individual with antibiotics and antitoxin
Testing and treating the infected person’s close contact with antibiotics and advising them to get the necessary vaccinations.
Keeping up with proper hygiene and steering clear of contaminated things or skin blemishes
Biology and molecular epidemiology of diphtheria toxin and the tox gene – PubMed (nih.gov)
Corynebacterium Diphtheriae – Medical Microbiology – NCBI Bookshelf (nih.gov)
Loading...
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
